Basic Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1349-1365
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1349
Figure 6
Figure 6 Expression of damage associated molecular patterns on the surface of peripheral blood CD45+ and CD45 cells and T cells from matched pre and post-treatment oesophageal adenocarcinoma patients. The expression of HMGB1 and calreticulin was determined on the surface of peripheral blood A) CD45+ and CD45- cells and B) CD3+, CD3+ CD4+, CD3+ CD8+ in matched pre and post treatment (CROSS regimen) whole blood (n = 5) ex vivo by flow cytometry. aP < 0.05.